Search:
   

Monday, May 13, 2024

Equity Corporate Actions Alert #2024 - 230
(UPDATED: SH approval rec'd & Form 10 declared effective) Spin-Off/Distribution Information for Inhibrx, Inc. (INBX)

Category:

  • Industry Announcement

Markets Impacted:

Contact Information:

Resources:

On January 23, 2024, Inhibrx, Inc. (INBX) announced that prior to the closing of a merger with Sanofi (SNY) the company will spin-off all non-101 assets and liabilities, including INBRX-105, INBRX-106, INBRX-109, Inhibrx's non-101 discovery pipeline and its corporate infrastructure into a separate publicly traded company, Inhibrx Biosciences, Inc. The EX distribution when-issued market of Inhibrx, Inc. (INBXV) and the when-issued market for Inhibrx Biosciences, Inc. Common Stock (INXBV) will begin trading on Nasdaq on Tuesday, May 28, 2024. The details for the spin-off and when-issued markets are as follows:

Parent Company/Issue: Inhibrx, Inc. Common Stock
CUSIP: 45720L107
Symbol: INBX
Record Date: May 17, 2024
Payment Date: May 29, 2024
EX Date: May 30, 2024
Due Bill Redeemable Date: May 30, 2024
Ratio of Spin-Off/ Distribution:
 One (1) share of Inhibrx Biosciences, Inc. Common Stock (INXB) for every four (4) shares of Inhibrx, Inc. (INBX) held.

An EX distribution when issued market will be established for Inhibrx, Inc. (INBXV) on the Nasdaq Global Market. Trades in the EX distribution when issued market will not carry due-bills for the spin off/distribution. The details for the EX distribution when-issued market are as follows:

Symbol: INBXV
CUSIP: 45720L115
First Trade Date: May 28, 2024
Suspension Date: May 30, 2024
Settlement Date: May 31, 2024

A when-issued market will be established for the shares of Inhibrx Biosciences, Inc. (INXBV) on the Nasdaq Global Select Market. The symbol will change to INXB on May 30, 2024. The details for the when issued market are as follows:

Symbol: INXBV
CUSIP: 45720N103
First Trade Date: May 28, 2024
Regular Way Trading Begins: May 30, 2024
Settlement Date: May 31, 2024
Additionally, subsequent to the completion of the merger of Inhibrx, Inc. and Sanofi (SNY), Inhibrx Biosciences, Inc. will change its symbol from INXB to INBX effective Friday, May 31, 2024. The details for the symbol change are as follows:

Company Name: Inhibrx Biosciences, Inc.
CUSIP: 45720N103
Symbol: INXB
New Symbol: INBX
Effective Date: May 31, 2024

For information regarding this announcement, contact Nasdaq Corporate Data Operations at +1 877 308 0523.

If you would like to register as a market maker in INBXV or INXBV contact Nasdaq Trading Services at +1 212 231 5100.

Email Alert Subscriptions:
Nasdaq offers customers the ability to self select news delivery across various Nasdaq markets. Create and maintain a profile for updating alert preferences and contact information. Visit the enrollment form on the Nasdaq Trader website and sign up today! Please note that if you choose to unsubscribe from an email list, you may no longer receive potentially critical emails from the NASDAQ Stock Market regarding Nasdaq's trading and data products, regulatory issues or marketplace initiatives. To unsubscribe, also click on the enrollment form

Please follow Nasdaq on Facebook RSS and Twitter.

Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 90 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to approximately 3,900 total listings with a market value of approximately $13 trillion. To learn more, visit: business.nasdaq.com.

View NASDAQTrader.com Mobile